Mauna Kea Technologies S.A.
ALMKT.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.17M
Close$
Share Statistics
| Market cap | $30.17 Million |
|---|---|
| Enterprise Value | $56.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.06 |
| Beta | 0.94 |
| Outstanding Shares | 191,833,000 |
Return
| Return on Equity | 2.23% |
|---|---|
| Return on Assets | -2.25% |
| Return on Invested Capital | -177.99% |
Valuation & Multiples
| P/E Ratio | 1.51 |
|---|---|
| PEG | 48.37 |
| Price to Sales | - |
| Price to Book Ratio | -0.1 |
| Enterprise Value to Revenue | 3.55 |
| Enterprise Value to EBIT | -4.45 |
| Enterprise Value to Net Income | -127 |
| Total Debt to Enterprise | 0.52 |
| Debt to Equity | -1.48 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 8, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
April 22, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Mauna Kea Technologies S.A.
59 employees
CEO: Sacha Loiseau Mauna Kea Technologies SA operates as a medical device enterprise, producing and distributing its offerings throughout Europe and worldwide. Its product line serves various medical specialties such as gastroenterology, pulmonology, and u...